Transarterial chemoembolisation (TACE) is a minimally invasive procedure in which chemotherapy is given directly into the cancer in your liver, under X-ray control. At the same time the blood supply to the cancer is blocked off, which allows for a higher dose of chemotherapy drug to be used because less of the drug is able to circulate to healthy cells in the body. Cutting off the blood supply to the tumour is part of the process of causing tumour necrosis (death) of the tumour.
TACE is suitable for patients whose cancer has started in the liver (hepatocellular carcinoma or HCC) along with certain tumours which have spread to the liver eg, neuroendocrine, melanoma. The liver must be functioning well in order to cope with the chemotherapy and the 'blocking-off' of the blood supply to the cancer in the liver.